Clobot클로봇
466100 · KOSDAQ · ₩466100 · 클로봇
₩18,800▼ ₩1,250 (6.23%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|---|
| Revenue | ₩8.9B | ₩8.1B | ₩18B | ₩11B | ₩7.8B | ₩4.9B |
| Cost of sales | ₩7.4B | ₩6.3B | ₩13B | ₩7B | ₩6.3B | ₩4.7B |
| Gross profit | ₩1.4B | ₩1.8B | ₩4.9B | ₩3.7B | ₩1.5B | ₩209M |
| Operating income | −₩2.8B | −₩2.5B | ₩1.3B | ₩771M | −₩1.9B | −₩3.4B |
| Net income | −₩427M | −₩2.2B | −₩3.3B | ₩2.5B | ₩1.6B | −₩3B |
| Net income to shareholders | −₩427M | −₩2.2B | −₩3.3B | ₩2.5B | ₩1.6B | −₩3B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|---|
| Total assets | ₩72B | ₩67B | ₩73B | ₩74B | ₩71B | ₩71B |
| Current assets | ₩63B | ₩62B | ₩70B | ₩70B | ₩67B | ₩67B |
| Cash and equivalents | ₩22B | ₩2.1B | ₩13B | ₩2.3B | ₩17B | ₩3.7B |
| Total liabilities | ₩14B | ₩9B | ₩13B | ₩15B | ₩14B | ₩14B |
| Current liabilities | ₩10B | ₩7.2B | ₩11B | ₩13B | ₩12B | ₩13B |
| Borrowings | ₩992M | ₩912M | ₩979M | ₩881M | ₩787M | ₩835M |
| Total equity | ₩58B | ₩58B | ₩60B | ₩59B | ₩57B | ₩58B |
| Shareholders' equity | ₩58B | ₩58B | ₩60B | ₩59B | ₩57B | ₩57B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|---|---|
| Cash from operations | −₩3.2B | −₩3.1B | ₩2.7B | ₩1.7B | −₩8.7B | ₩1.4B |
| Capital spending | ₩335M | ₩1B | −₩318M | ₩288M | ₩287M | ₩39M |
| Free cash flow | −₩3.5B | −₩4.1B | ₩2.4B | ₩1.4B | −₩9B | ₩1.4B |
Consolidated where available. Amounts in won.
Also known as: Clobot / 클로봇 / 466100 / KRX:466100
Source: KRX statistical information